Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response.
about
Autoantibodies in chronic hepatitis C: A clinical perspectivePossible factors affecting thyroid dysfunction in hepatitis C virus-infected untreated patientsAutoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients.Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.Extrahepatic immune related manifestations in chronic hepatitis C virus infection.Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.
P2860
Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Serum autoantibodies positivit ...... ribavirin treatment response.
@en
Serum autoantibodies positivit ...... ribavirin treatment response.
@nl
type
label
Serum autoantibodies positivit ...... ribavirin treatment response.
@en
Serum autoantibodies positivit ...... ribavirin treatment response.
@nl
prefLabel
Serum autoantibodies positivit ...... ribavirin treatment response.
@en
Serum autoantibodies positivit ...... ribavirin treatment response.
@nl
P2093
P2860
P356
P1433
P1476
Serum autoantibodies positivit ...... ribavirin treatment response.
@en
P2093
Badawy El-Kholy
Gamal Esmat
Hany Khatab
Mahassen Mabrouk
Maissa El-Raziky
Marwa Khairy
Mohamed S Abdelbary
Wafaa El-Akel
P2860
P304
P356
10.1111/LIV.12227
P577
2013-06-14T00:00:00Z